Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile

Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
72 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative medicine. Its lead technology platform, SurgWerks is used for the collection, separation, storage and delivery of stem cells from adult tissue sources including cord blood and bone marrow. The companys CellWerks MXP system is an integrated protocol and equipment with disposables for rapid intra-laboratory use under the direction of a licensed physician. It finds application in bone marrow transplantation and cellular purification from cord blood.

Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals i

  
Source:
Document ID
GDME460D
Country
Industry
Ticker
KOOL=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Cesca Therapeutics Inc., Medical Equipment, Deals By Year, 2010 to YTD 201652
Cesca Therapeutics Inc., Medical Equipment Deals By Type, 2010 to YTD 201671
Cesca Therapeutics Inc., Medical Equipment, Deals By Region, 2010 to YTD 201681
Cesca Therapeutics Inc., Medical Equipment, Deals By Market, 2010 to YTD 201691
Cesca Therapeutics Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016102
Cesca Therapeutics Inc., Medical Equipment, Deal Details1229
  Partnerships121
    ThermoGenesis Enters Into Licensing Agreement With BioParadox121
    Asahi Kasei Kuraray Medical And ThermoGenesis Amends Licensing Agreement131
    Cesca Therapeutics Amends Licensing Agreement with CBR Systems141
    Texas Stem Cell Enters into Agreement with Cesca Therapeutics151
    Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec161
    ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings171
    Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System181
    ThermoGenesis Enters Into Distribution Agreement With Nanshan Memorial Medical191
    ThermoGenesis Signs Distribution Agreement With GE Healthcare201
    ThermoGenesis Enters Into Distribution Agreement With Fenwal211
  Merger221
    TotipotentRx Completes Merger With ThermoGenesis222
  Equity Offering241
    Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million242
    Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares262
    Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units282
    ThermoGenesis Completes Private Placement Of Common Stock And Warrants For US$6.7 Million302
    ThermoGenesis Completes Public Offering Of Units For US$4.5 Million322
  Debt Offering341
    Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019341
    Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045351
  Asset Transactions361
    Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis362
    Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For US$2 Million382
    ThermoGenesis To Sell CryoSeal Fibrin Sealant System Wound Care Product Line401
Cesca Therapeutics Inc. - Key Competitors411
Key Employees421
Locations And Subsidiaries431
  Head Office431
  Other Locations &Subsidiaries431
Recent Developments441
Financial Announcements441
Sep 20, 2016: Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results442
May 12, 2016: Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update461
Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors471
Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results482
Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results502
Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results521
Feb 12, 2015: Cesca Therapeutics Reports Second Quarter Fiscal 2015 Results531
Corporate Communications541
Jun 20, 2016: Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors541
Mar 23, 2016: Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D., to its Clinical Advisory Board551
Mar 10, 2016: Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of Directors561
Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics571
Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics581
Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative591
Jun 12, 2015: Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer601
May 04, 2015: Cesca Therapeutics Announces Changes in Management611
Product News621
Dec 02, 2015: Cesca Receives Approval for Medicare Coverage621
Oct 23, 2015: Cesca Therapeutics to Present Progress on Its CellWerks Product Pipeline at the AABB Conference in Anaheim, California, October 24-27631
May 13, 2015: Cesca Therapeutics Submits U.S. Pivotal IDE Amendment Application for Late Stage Critical Limb Ischemia (CLI)641
Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Acute Myocardial Infarction651
Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia661
Feb 11, 2015: Cesca Therapeutics Announces Approval of its MarrowXpress System in India671
Product Approvals681
Feb 11, 2015: Cesca Therapeutics Announces Approval of its MarrowXpress System in India681
Clinical Trials691
Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Acute Myocardial Infarction691
Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia701
Other Significant Developments711
Oct 19, 2015: Cesca Therapeutics Clinical Laboratory Successfully Facilitates Haploidentical Bone Marrow Transplant Procedure on Unique Pediatric Patient in Need711
Appendix721
  Methodology721
  About GlobalData721
  Contact Us721
  Disclaimer721

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Cesca-Therapeutics-Inc-KOOL-Medical-Equipment-Deals-and-Alliances-Profile-2148-5342>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Cesca Therapeutics Inc. (KOOL) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Cesca-Therapeutics-Inc-KOOL-Medical-Equipment-Deals-and-Alliances-Profile-2148-5342>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research